类风湿关节炎的慢病管理

doi:10.16138/j.1673-6087.2022.03.006

摘要/Abstract

关键词: 类风湿关节炎, 达标治疗, 慢病管理, 自身免疫病

中图分类号:

R593.22

王宏智, 袁昳玮. 类风湿关节炎的慢病管理[J]. 内科理论与实践, 2022, 17(03): 202-207.

图/表 2

参考文献 40

[1]	田新平, 李梦涛, 曾小峰. 我国类风湿关节炎诊治现状与挑战:来自中国类风湿关节炎2019年年度报告[J]. 中华内科杂志, 2021, 60(7): 593-598.
[2]	周云杉, 王秀茹, 安媛, 等. 全国多中心类风湿关节炎患者残疾及功能受限情况的调查[J]. 中华风湿病学杂志, 2013, 17(8): 526-532.
[3]	Massarenti L, Enevold C, Damgaard D, et al. PADI4 polymorphisms confer risk of anti-CCP-positive rheumatoid arthritis in synergy with HLA-DRB1*04 and smoking[J]. Front Immunol, 2021, 12: 707690. doi: 10.3389/fimmu.2021.707690 URL
[4]	Larid G, Pancarte M, Offer G, et al. In rheumatoid arthritis patients, HLA-DRB1*04:01 and rheumatoid nodules are associated with ACPA to a particular fibrin epitope[J]. Front Immunol, 2021, 12: 692041. doi: 10.3389/fimmu.2021.692041 URL
[5]	Arleevskaya M, Takha E, Petrov S, et al. Causal risk and protective factors in rheumatoid arthritis[J]. J Transl Autoimmun, 2021, 4: 100119. doi: 10.1016/j.jtauto.2021.100119 URL
[6]	Hashimoto A, Matsui T. Risk of serious infection in patients with rheumatoid arthritis[J]. Nihon Rinsho Meneki Gakkai Kaishi, 2015, 38(2): 109-115. doi: 10.2177/jsci.38.109 pmid: 26016638
[7]	Liu Z, Wu Y, Luo Y, et al. Self-balance of intestinal flora in spouses of patients with rheumatoid arthritis[J]. Front Med (Lausanne), 2020, 7: 538.
[8]	Drummond PD, Willox M. Painful effects of auditory startle, forehead cooling and psychological stress in patients with fibromyalgia or rheumatoid arthritis[J]. J Psychosom Res, 2013, 74(5): 378-383. doi: 10.1016/j.jpsychores.2013.01.011 pmid: 23597324
[9]	Adawi M, Sabbah F, Tzischinsky O, et al. Sleep disorders and vascular responsiveness in patients with rheumatoid arthritis[J]. J Intern Med, 2020, 288(4): 439-445. doi: 10.1111/joim.13087 pmid: 32330326
[10]	Anderson R, Meyer PW, Ally MM, et al. Smoking and air pollution as pro-inflammatory triggers for the development of rheumatoid arthritis[J]. Nicotine Tob Res, 2016, 18(7): 1556-1565. doi: 10.1093/ntr/ntw030 pmid: 26957528
[11]	Bae SC, Lee YH. Alcohol intake and risk of rheumatoid arthritis: a Mendelian randomization study[J]. Z Rheumatol, 2019, 78(8): 791-796. doi: 10.1007/s00393-018-0537-z pmid: 30209555
[12]	Meisters R, Putrik P, Ramiro S, et al. EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries[J]. Ann Rheum Dis, 2020, 79(11): 1423-1431.
[13]	蒋黎纯, 杨清萍, 王宏智. 嘉兴地区人群维生素D水平及其影响因素[J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(4): 375-377.
[14]	Fukuda W, Omoto A, Oku S, et al. Contribution of rheumatoid arthritis disease activity and disability to rheumatoid cachexia[J]. Mod Rheumatol, 2010, 20(5): 439-443. doi: 10.3109/s10165-010-0306-6 URL
[15]	Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis[J]. Arthritis Rheum,1988, 31(3): 315-324. doi: 10.1002/art.1780310302 URL
[16]	Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative[J]. Arthritis Rheum, 2010, 62(9): 2569-2581. doi: 10.1002/art.27584 URL
[17]	Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis[J]. Lancet, 2017, 389(10086): 2338-2348. doi: S0140-6736(17)31491-5 pmid: 28612748
[18]	van der Linden MP, Knevel R, Huizinga TW, et al. Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria[J]. Arthritis Rheum, 2011, 63(1): 37-42. doi: 10.1002/art.30100 URL
[19]	叶华, 苏茵, 李茹, 等. 早期类风湿关节炎分类标准的全国多中心临床验证[J]. 中华风湿病学杂志, 2014, 18(12): 802-805.
[20]	Thevissen K, Vercoutere W, Bombardier C, et al. Diagnostic and prognostic value of synovial biopsy in adult undifferentiated peripheral inflammatory arthritis[J]. J Rheumatol Suppl, 2011, 87: 45-47. doi: 10.3899/jrheum.101074 pmid: 21364056
[21]	中华医学会风湿病学分会. 2018中国类风湿关节炎诊疗指南[J]. 中华内科杂志, 2018, 57(4): 242-251.
[22]	Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis[J]. Arthritis Care Res (Hoboken), 2021, 73(7): 924-939. doi: 10.1002/acr.24596 pmid: 34101387
[23]	风湿免疫疾病慢病管理全国护理协作组. 类风湿关节炎患者的慢病管理专家共识(2014版)[J]. 中华风湿病学杂志, 2016, 20(2): 127-131.
[24]	曾小峰, 魏李培. 风湿免疫科医生奇缺[N]. 健康报,2013-07-01(007).
[25]	Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial[J]. Lancet, 2004, 364(9430): 263- doi: 10.1016/S0140-6736(04)16676-2 URL
[26]	Klarenbeek NB, Güler-Yüksel M, van der Kooij SM, et al. The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study[J]. Ann Rheum Dis, 2011, 70(6): 1039-1046. doi: 10.1136/ard.2010.141234 pmid: 21415052
[27]	Smolen JS, Aletaha D, Bijlsma JW, et al. Treating rheumatoid arthritis to target: recommendations of an international task force[J]. Ann Rheum Dis, 2010, 69(4): 631-637. doi: 10.1136/ard.2009.123919 pmid: 20215140
[28]	Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis[J]. Arthritis Care Res (Hoboken), 2016, 68(1): 1-25. doi: 10.1002/acr.22783 URL
[29]	Yu Z, Lu B, Agosti J, et al. Implementation of treat-to-target for rheumatoid arthritis in the US: analysis of baseline data from a randomized controlled trial[J]. Arthritis Care Res (Hoboken), 2018, 70(5): 801-806. doi: 10.1002/acr.23343 URL
[30]	Lau CS, Chia F, Dans L, et al. 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis[J]. Int J Rheum Dis, 2019, 22(3): 357-375. doi: 10.1111/1756-185X.13513 URL
[31]	Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update[J]. Ann Rheum Dis, 2020, 79(6): 685-699. doi: 10.1136/annrheumdis-2019-216655 pmid: 31969328
[32]	Allen A, Carville S, McKenna F, et al. Diagnosis and management of rheumatoid arthritis in adults: summary of updated NICE guidance[J]. BMJ, 2018, 362 : k3015.
[33]	Smolen JS, Landewé R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update[J]. Ann Rheum Dis, 2017, 76(6): 960-977. doi: 10.1136/annrheumdis-2016-210715 pmid: 28264816
[34]	Nagy G, Roodenrijs NMT, Welsing PMJ, et al. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis[J]. Ann Rheum Dis, 2021, 81(1): 20-33.
[35]	Smolen JS, Boers M, Abadie EC, et al. Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA[J]. Curr Med Res Opin, 2011, 27(2): 315-325. doi: 10.1185/03007995.2010.542135 pmid: 21142618
[36]	Rannio T, Asikainen J, Kokko A, et al. Early remission is a realistic target in a majority of fatients with DMARD-naive rheumatoid arthritis[J]. J Rheumatol, 2016, 43(4): 699-706. doi: 10.3899/jrheum.141480 URL
[37]	Mathias K, Amarnani A, Pal N, et al. Chronic pain in patients with rheumatoid arthritis[J]. Curr Pain Headache Rep, 2021, 25(9): 59. doi: 10.1007/s11916-021-00973-0 URL
[38]	Elangovan S, Tan YK. The role of musculoskeletal ultrasound imaging in rheumatoid arthritis[J]. Ultrasound Med Biol, 2020, 46(8): 1841-1853. doi: 10.1016/j.ultrasmedbio.2020.04.015 URL
[39]	Jaffe DH, Lee L, Huynh S, et al. Health Inequalities in the Use of Telehealth in the United States in the Lens of COVID-19[J]. Popul Health Manag, 2020, 23(5): 368-377. doi: 10.1089/pop.2020.0186 URL
[40]	Chang JE, Lai AY, Gupta A, et al. Rapid transition to telehealth and the digital divide:implications for primary care access and equity in a post-COVID era[J]. Milbank Q, 2021, 99(2): 340-368. doi: 10.1111/1468-0009.12509 pmid: 34075622

类风湿关节炎的慢病管理

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 2

参考文献 40

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李佳, 吕良敬. 靶向治疗时代议自身免疫病的感染挑战[J]. 诊断学理论与实践, 2022, 21(03): 299-303.
[2]	陆弘逾, 顾俊, 王静, 曹亚峰, 宋陆茜, 范俊, 陈梅. 干燥综合征继发隐球菌性脑膜脑炎一例报告及相关自身免疫病文献复习[J]. 诊断学理论与实践, 2021, 20(05): 456-461.
[3]	吴歆, 耿旭强, 徐沪济. 多基因风险评分在复杂性状疾病中的应用进展[J]. 诊断学理论与实践, 2020, 19(05): 540-543.
[4]	袁昳玮, 顾娟芳, 费张丽, 杨明峰, 王艺文, 王宏智. 程序性细胞死亡因子5在活动性类风湿关节炎患者中的水平变化[J]. 诊断学理论与实践, 2018, 17(04): 453-456.
[5]	刘玮, 吴歆, 徐沪济. 类风湿关节炎易感基因遗传背景的研究进展[J]. 诊断学理论与实践, 2018, 17(03): 347-351.
[6]	赵智明, 刘春丽, 商玮, 常文静, 张群燕, 张蓓蓓, 蔡辉,. 肺与类风湿关节炎[J]. 内科理论与实践, 2017, 12(06): 419-421.
[7]	杨菁, 包扬, 庞小芬, 聂子淮, 崔羽. 有氧运动对类风湿关节炎患者自评健康状况影响的荟萃分析[J]. 诊断学理论与实践, 2017, 16(03): 328-332.
[8]	汪思阳, 沈展, 沈婷婷, 曲伸, 席蓓莉,. 补充维生素D对骨质疏松症和骨量减少患者骨密度和骨折风险的影响[J]. 内科理论与实践, 2016, 11(02): 80-83.
[9]	张冬青,. 干扰素-β/抗白细胞介素-6受体单抗干预类风湿关节炎机制的新认识[J]. 诊断学理论与实践, 2015, 14(02): 99-104.
[10]	许荣, 周晓薇, 陈呢喃, 赵蓉, 苗平, 钱柳, 胡朝英, 余奇文, 张继英, 何东仪, 肖连波, 张冬青,. 类风湿关节炎患者自身抗体及关节损伤因子检出的临床意义[J]. 诊断学理论与实践, 2014, 13(03): 260-266.
[11]	闫丽娟, 王晶石, 王昭,. 自身免疫病相关噬血细胞综合征22例临床分析[J]. 内科理论与实践, 2013, 8(03): 182-186.
[12]	王晓栋, 杨程德,. 类风湿关节炎的达标治疗[J]. 内科理论与实践, 2011, 6(05): 390-392.
[13]	高源, 张冬青,. 类风湿关节炎的遗传学研究进展[J]. 诊断学理论与实践, 2011, 10(05): 486-490.
[14]	钱柳, 黄秋愉, 胡朝英, 程伟志, 苗平, 缪怡, 余奇文, 张继英, 陈雪华, 何东仪, 李卓凌, 许荣, 张冬青,. 类风湿关节炎患者自身反应性B细胞异常表达相关分子的检测和分析[J]. 诊断学理论与实践, 2011, 10(01): 55-61.
[15]	吕芳, 李兴福,. 2010年美国风湿病学会联合欧洲抗风湿病联盟的类风湿关节炎分类标准解读[J]. 诊断学理论与实践, 2010, 9(04): 307-310.